These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18190861)

  • 1. Development trends for new cancer therapeutics and vaccines.
    Reichert JM; Wenger JB
    Drug Discov Today; 2008 Jan; 13(1-2):30-7. PubMed ID: 18190861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development trends for monoclonal antibody cancer therapeutics.
    Reichert JM; Valge-Archer VE
    Nat Rev Drug Discov; 2007 May; 6(5):349-56. PubMed ID: 17431406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economics of new oncology drug development.
    DiMasi JA; Grabowski HG
    J Clin Oncol; 2007 Jan; 25(2):209-16. PubMed ID: 17210942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technical challenges facing therapeutic cancer vaccines.
    Ward S; Copier J; Dalgleish A
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):168-77. PubMed ID: 18283604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TG-4010 Transgene.
    Cohen S; Kaufman HL
    Curr Opin Investig Drugs; 2004 Dec; 5(12):1319-28. PubMed ID: 15648954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current trends in the clinical development of peptide therapeutics.
    Saladin PM; Zhang BD; Reichert JM
    IDrugs; 2009 Dec; 12(12):779-84. PubMed ID: 19943221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic recombinant proteins: trends in US approvals 1982 to 2002.
    Reichert JM; Paquette C
    Curr Opin Mol Ther; 2003 Apr; 5(2):139-47. PubMed ID: 12772503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically based therapeutics for cancer: similarities and contrasts with traditional drug discovery and development.
    Hermiston TW; Kirn DH
    Mol Ther; 2005 Apr; 11(4):496-507. PubMed ID: 15771953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in development and approval times for new therapeutics in the United States.
    Reichert JM
    Nat Rev Drug Discov; 2003 Sep; 2(9):695-702. PubMed ID: 12951576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic cancer vaccines on trial.
    Reichert JM; Paquette C
    Nat Biotechnol; 2002 Jul; 20(7):659-63. PubMed ID: 12089545
    [No Abstract]   [Full Text] [Related]  

  • 11. Melanoma vaccines: possible progress after years of frustration?
    Schmidt C
    J Natl Cancer Inst; 2009 Feb; 101(3):140-1. PubMed ID: 19176461
    [No Abstract]   [Full Text] [Related]  

  • 12. Development and economic trends in cancer therapeutic drugs in the UK from 1955 to 2009.
    Savage P
    J Oncol Pharm Pract; 2012 Mar; 18(1):52-6. PubMed ID: 21109615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons from randomized phase III studies with active cancer immunotherapies--outcomes from the 2006 meeting of the Cancer Vaccine Consortium (CVC).
    Finke LH; Wentworth K; Blumenstein B; Rudolph NS; Levitsky H; Hoos A
    Vaccine; 2007 Sep; 25 Suppl 2():B97-B109. PubMed ID: 17916465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drugs in India over the past 15 years: analysis of trends.
    Ghosh A; Hazra A; Mandal SC
    Natl Med J India; 2004; 17(1):10-6. PubMed ID: 15115225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New frontiers in cell-based immunotherapy of cancer.
    D'Elios MM; Del Prete G; Amedei A
    Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological aspects of cancer chemotherapy.
    Zitvogel L; Apetoh L; Ghiringhelli F; Kroemer G
    Nat Rev Immunol; 2008 Jan; 8(1):59-73. PubMed ID: 18097448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the efficacy of cancer immunotherapy.
    Copier J; Dalgleish AG; Britten CM; Finke LH; Gaudernack G; Gnjatic S; Kallen K; Kiessling R; Schuessler-Lenz M; Singh H; Talmadge J; Zwierzina H; Håkansson L
    Eur J Cancer; 2009 May; 45(8):1424-31. PubMed ID: 19167214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials and biomarker development with molecularly targeted agents and radiotherapy.
    Dhani N; Siu LL
    Cancer Metastasis Rev; 2008 Sep; 27(3):339-49. PubMed ID: 18379730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic survey of therapeutic trials for metastatic colorectal cancer: room for improvement in the critical pathway.
    Kopetz S; Overman M; Chang DZ; Glover KY; Shureiqi I; Wolff RA; Abbruzzese JL; Eng C
    J Clin Oncol; 2008 Apr; 26(12):2000-5. PubMed ID: 18421052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bispecific antibodies for cancer therapy.
    Chames P; Baty D
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):276-83. PubMed ID: 19333873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.